[Clinical studies on extracorporeal circulation with increased hemodilution. II. Oxygen utilization with special reference to optimal flow rate].
D000136:Acid-Base Equilibrium; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D001776:Blood Circulation Time; D001811:Blood Volume Determination; D002245:Carbon Dioxide / Q000097:blood; D002306:Cardiac Volume; D002648:Child; D002675:Child, Preschool; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D005112:Extracorporeal Circulation; D006330:Heart Defects, Congenital / Q000601:surgery*; D006349:Heart Valve Diseases / Q000601:surgery; D006355:Heart-Lung Machine; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D006454:Hemoglobins; D002245:Carbon Dioxide; D003402:Creatine Kinase; D010100:Oxygen
Klinische Studien des extrakorporalen Kreislaufs mit verstärkter Hämodilution. II. Uber die Sauerstoffausnutzung unter besonderer Berücksichtigung der optimalen Flussrate.